Modem methods for assessing the drugs used in the chemotherapy of mycobacterial disease

Journal of Applied Microbiology Symposium Supplement

Volumn 81, Issue , 1996, Pages

  Mitchison, O A ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; ETHAMBUTOL; ISONIAZID; PAROMOMYCIN; RIFABUTIN; RIFAPENTINE; STREPTOMYCIN; THIOACETAZONE; ANTIINFECTIVE AGENT; DRUG DERIVATIVE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

BACTERICIDAL ACTIVITY; CHEMOTHERAPY; DRUG ACTIVITY; DRUG EFFICACY; HUMAN; MYCOBACTERIOSIS; REVIEW; SPUTUM; BACTERIAL COUNT; CLINICAL TRIAL; DRUG EFFECT; DRUG SCREENING; LUNG TUBERCULOSIS; METHODOLOGY; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; RECURRENT DISEASE; STATISTICS; TIME;

ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTITUBERCULAR; ANTITUBERCULAR AGENTS; CLINICAL TRIALS; COLONY COUNT, MICROBIAL; DRUG EVALUATION; HUMANS; MYCOBACTERIUM TUBERCULOSIS; PAROMOMYCIN; RECURRENCE; RIFABUTIN; RIFAMPIN; SPUTUM; TIME FACTORS; TUBERCULOSIS, PULMONARY;

EID: 0029658356     PISSN: 02674440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Botha, F.J.H., Sirgel, F.A., Parkin, O.P., van de Wal, B.W., Donald, P.R. and Mitchison, D.A. (1996) The early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (rifater) in patients with pulmonary tuberculosis. South African Medical Journal 86, 155-158.
2. British Thoracic Association (1981) A controlled trial of six months chemotherapy in pulmonary tuberculosis. First report. British Journal of Diseases of the Chest 75, 141-153.
3. British Thoracic Association (1982) A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report. American Renew of Respiratory Disease 126, 460-1-62.
4. Broekmans, J.F. (1994) Control strategies and programme management. In Tuberculosis : Back to the Future ed. Porter, J.D.H. and McAdam, K.P.W.J. p. 183. Chichester : Wiley.
5. Chan, S.L., Yew, W.W., Ma, W.K., Girling, D.J., Aber, V.R., Felmingham, D., Allen, B.W. and Mitchison, D.A. (1992) The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis. Tubercle and Lung Disease 73, 33 38.
6. Dhillon, J. and Mitchison, D.A. (1989) Activity and penetration of antituberculosis drugs in mouse peritoneal macrophages infected with Myciibacteriiim micron OV254. Antimicrobial Agents ami Chemotherapy 33, 1255-1259.
7. East African/British Medical Research Council (1966) Isoniazid with thiaceta/one (thioacetazone) in the treatment of pulmonary tuberculosis in Fast Africa-third investigation. Tubercle 47, 1-32.
8. East African/British Medical Research Council (1973) Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Lancet 1, 1331-1339.
9. East African/British Medical Research Council (1974a) Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Third report. Lancet 2, 237-240.
10. East African/British Medical Research Council (1974b) Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for the treatment of pulmonary tuberculosis. Lancet 2, 1100-1106.
11. East African/British Medical Research Council (1976) Controlled clinical trial of four 6-month regimens of chemotherapy for pulmonary tuberculosis. Second report. American Review of Respiratury Disease 114, 471-475.
12. East African/British Medical Research Council (1978) Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis. First report. American Review nj Respiratory Disease 118, 39-48.
13. East African/British Medical Research Council (1980) Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis. Tubercle 61, 59-69.
14. East African/British Medical Research Council (1981) Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis : second report of the 4th study. American Review of Respiratory Disease 123, 165-170.
15. Fox, W., Sutherland, I. and Daniels, M. (1954) A five-year assessment of patients in a controlled trial of streptomycin in pulmonary tuberculosis. Quarterly Journal of Medicine 23, 347-366.
16. Gonzalex-Montaner, L.J., Natal, S., Yongchaiyud, P., Olliaro, P., the Rifabutin Study Group (1994) Rifabutin for the treatment of newly-diagnosed pulmonary tuberculosis : a multinational, randomized, comparative study versus Rifampicin. Tubercle and Lune. Disease 75, 341-347.
17. Grumbach, F., Canetti, G. and Le Lirzin, M. (1969) Rifampicin in daily and intermittent treatment of experimental murine tuberculosis, with emphasis on late results. Tubercle 50, 280-293.
18. Heifets, L. and Lindholm-Levy, P. (1990) Is pyra/inamide bactericidal against Mycobacteriitm tuberculosis'? American Review of Respiratory Disease 141, 250-252.
19. Heifets, L. and Lindholm-Levy, P. (1992) Pyraiinamide sterilizing activity in vitro against semidormant Mycobacterium tuberculosis bacterial populations. American Review oj Respiratory Disease 145, 1223-1225.
20. Hong Kong Chest Service/British Medical Research Council (1978) Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. American Review oj'Respiratory Disease 118, 219-227.
21. Hong Kong Chest Service/British Medical Research Council (1979) Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. Tubercle 60, 201-210.
22. Hong Kong Chest Service/British Medical Research Council (1982) Controlled trial of 4 three-times weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis. Tubercle 63, 89-98.
23. Hong Kong Chest Service/British Medical Research Council (1987) Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. American Review of Respiratory Disease 136, 1339-1342.
24. Hong Kong Chest Service/British Medical Research Council (1991) Controlled trial of 2, 4 and 6 months of pyrazinamidc in 6-month, 3 x weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin & pyrazinamide. American Review of Respiratory Disease 143, 700-706.
25. Jindani, A., Aber, V.R., Edwards, E.A. and Mitchison, D.A. (1980) The early bactericidal activity of drugs in patients with pulmonary tuberculosis. American Review of Respiratory Disease 121, 939-949.
26. Kanyok, T.P., Reddy, M.V., Chinnaswamy, J., Danziger, L.H. and Gangadharam, P.R.J. (1994a) In vivo activity of paromomycin against susceptible and multidrug-resistant Mycohacterium tuberculosis and M. avium complex strains. Antimicrobial Agents and Chemotherapy 38, 170-173.
27. Kanyok, T.P., Reddy, M.V., Chinnaswamy, J., Danziger, L.H. and Gangadharam, P.R.J. (1994b) Activity of aminosidine (paromyoycin) for Mycobacterium tuberculosis and Mycobacterium avium. Journal of Antimicrobial Chemotherapy 33, 323-327.
28. Medical Research Council (1948) Streptomycin treatment of pulmonary tuberculosis. British Medical Journal 2, 769-783.
29. Melero, C., Rey, R., Ussetti, P., Munoz, L., Caballero, J., Ortego, A. and Ramos, A. (1994) Rifabutin vs rifampicin in the treatment of initial pulmonary tuberculosis. Follow-up at 5 years. Tubercle and Lung Disease IS (Suppl. 1), 16-17.
30. Mitchison, D.A. (1985) The action of antituberculosis drugs in short-course chemotherapy. Tubercle 66, 219-225.
31. Mitchison, D.A. (1992) The Garrod Lecture. Understanding the chemotherapy of tuberculosis-current problems. Journal of Antimicrobial Chemotherapy 29, 477-493.
32. Mitchison, D.A. (1995a) Early bactericidal activity and sterilizing activity of ciprofloxacin in pulmonary tuberculosis. American Journal of Respiratory and Critical Care Medicine 151, 921.
33. Mitchison, D.A. (1995b) Rifabutin in the treatment of newly diagnosed pulmonary tuberculosis. Tubercle and Lung Disease 76, 277.
34. Mitchison, D.A. and Nunn, A.J. (1986) Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. American Review of Respiratory Disease 133, 423-430.
35. Rastogi, N., Potar, M.-C. and David, H.L. (1988) Pyrazinamide is not effective against intracellularly growing Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 32, 287.
36. Salfinger, M., Crowle, A.J. and Relier, L.B. (1990) Pyrazinamide and pyrazinoic acid activity against tubercle bacilli in cultured human macrophages and in the Bactec system. Journal of Infectious Diseases 162, 201-220.
37. Santha, T., Nazareth, O., Krishnamurthy, M.S., Balasubramanian, R., Vijayan, V.K., Janardhanam, B. et al. (1989) Treatment of pulmonary tuberculosis with short course chemotherapy in South India-5 year follow up. Tubercle 70, 229-234.
38. Schwander, S., Rusch-Gerdes, S., Mateega, A., Lutalo, T., Tugume, S., Kityo, G. et al. (1995) A pilot study of antituberculosis combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis. Tubercle and Lung Disease 76, 210-218.
39. Singapore Tuberculosis Service/British Medical Research Council (1985) Clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. American Review of Respiratory Disease 132, 374-378.
40. Singapore Tuberculosis Service/British Medical Research Council (1991) Assessment of a daily combined preparation of isoniazid, rifampin and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. American Review of Respiratory Disease 143, 707-712.
41. Sirgel, F.A., Botha, F.J.H., Parkin, O.P., van De Wal, B.W., Donald, P.R. and Mitchison, D.A. (1994) Early bactericidal activity as a method of assessment of drugs for the treatment of tuberculosis. Journal of Antimicrobial Chemotherapy 34, 181-190.
42. Sirgel, F.A., Botha, F.J.H., Parkin, O.P., van De Wal, B.W., Donald, P.R., Clark, P.K. and Mitchison, D.A. (1993) The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts. A new method of drug Assessment. Journal of Antimicrobial Chemotherapy 32, 867-875.
43. Tuberculosis Chemotherapy Centre, Madras (1960) A concurrent comparison of isoniazid plus PAS with three regimens of isoniazid alone in the domiciliary treatment of pulmonary tuberculosis in South India. Bulletin of the World Health Organisation 23, 535-585.
44. Tuberculosis Research Centre, Madras (1983) Study of chemotherapy regimens of 5 and 7 months' duration and the role of corticosteroids in the treatment of sputum-positive patients with pulmonary tuberculosis in South India. Tubercle 64, 73-91.
45. Tuberculosis Research Centre Madras/National Tuberculosis Institute, Bangalore (1986) A controlled clinical trial of 3- and 5-month regimens in the treatment of sputum-positive pulmonary tuberculosis in South India. American Review uf Respiratory Disease 134, 27-33.